Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality  Edward L. Hannan, PhD, Zaza Samadashvili,

Slides:



Advertisements
Similar presentations
Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Advertisements

Impact of Moderate Ischemic Mitral Regurgitation After Isolated Coronary Artery Bypass Grafting  Khalil Fattouch, MD, PhD, Roberta Sampognaro, MD, Giuseppe.
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Longitudinal Outcome of Isolated Mitral Repair in Older Patients: Results From 14,604 Procedures Performed From 1991 to 2007  Vinay Badhwar, MD, Eric.
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction  Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.
Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
One or Two Internal Thoracic Grafts
Predicting In-Hospital Mortality After Redo Cardiac Operations: Development of a Preoperative Scorecard  Sebastian Launcelott, BA, BComm, Maral Ouzounian,
Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis  Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.
Peter K. Smith, MD, Michel Carrier, MD, John C
Improved Mitral Valve Performance After Transapical Aortic Valve Implantation  Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger,
Valve Replacement for Severe Aortic Stenosis With Low Transvalvular Gradient and Left Ventricular Ejection Fraction Exceeding 0.50  Giuseppe Tarantini,
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Impact of Preoperative Renal Dysfunction on Long-Term Survival for Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, W. Brent Keeling,
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.
The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.
David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD 
The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery  Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.
Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008  Colin R. Lenihan, MBBCh, BAO, Maria E. Montez-Rath,
Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M
Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease  Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery?  Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,
Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients  Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.
Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery  Maral Ouzounian, MD, Karen J. Buth, MS,
New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery  Giovanni Filardo, PhD, MPH, Cody Hamilton,
Long-Term Mortality of Coronary Artery Bypass Graft Surgery and Stenting With Drug- Eluting Stents  Chuntao Wu, MD, PhD, Fabian T. Camacho, MS, Songyang.
Late Survival After Valve Operation in Patients With Left Ventricular Dysfunction  Ignacio G Duarte, Charles O Murphy, Andrzej S Kosinski, Ellis L Jones,
Chronic Atrial Fibrillation Is Associated With Reduced Survival After Aortic and Double Valve Replacement  Richard Schulenberg, MD, Polychronis Antonitsis,
Donald S. Likosky, PhD, Stephen D. Surgenor, MD, Robert S
Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,
Preoperative White Blood Cell Count is Independently Associated With Higher Perioperative Cardiac Enzyme Release and Increased 1-Year Mortality After.
Aortic Valve Replacement With Carpentier-Edwards: Hemodynamic Outcomes for the 19-mm Valve  Ji Hoon You, MD, PhD, Dong Seop Jeong, MD, PhD, Kiick Sung,
Fate of Functional Mitral Regurgitation and Predictors of Persistent Mitral Regurgitation After Isolated Aortic Valve Replacement  Hyun-Chel Joo, MD,
Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients  Giovanni Filardo, PhD, MPH,
Sam Chitsaz, MD, Nicolas Jaussaud, MD, Edward Chau, MD, Kimberly S
Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years  Khaled D. Algarni, MD, MHS, Manjula Maganti,
Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery  Sophie Piérard, MD, Christophe.
Bartosz Rylski, MD, Nimesh D. Desai, MD, PhD, Joseph E
Aortic Valve Replacement and Concomitant Coronary Artery Bypass: Assessing the Impact of Multiple Grafts  Kimiyoshi J. Kobayashi, BS, Jason A. Williams,
Vinod H. Thourani, MD, Vinay Badhwar, MD, David M. Shahian, MD, Fred H
Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy  Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.
Robert H. Habib, PhD, Thomas A. Schwann, MD, Milo Engoren, MD 
Aortic Regurgitation With Markedly Reduced Left Ventricular Function Is Not a Contraindication for Aortic Valve Replacement  Tsuyoshi Kaneko, MD, Julius.
Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era  Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,
The New York Risk Score for In-Hospital and 30-Day Mortality for Coronary Artery Bypass Graft Surgery  Edward L. Hannan, PhD, Louise Szypulski Farrell,
Impact of Functional Status on Survival After Coronary Artery Bypass Grafting in a Veteran Population  Roberto Cervera, MD, Faisal G. Bakaeen, MD, Lorraine.
Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction  Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Left Ventricular Reconstruction Benefits Patients With Dilated Ischemic Cardiomyopathy  Atsushi Yamaguchi, MD, Hideo Adachi, MD, Koji Kawahito, MD, Seiichiro.
Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?
Determinants and Prognosis of Myocardial Damage After Coronary Artery Bypass Grafting  Francesco Onorati, MD, Marisa De Feo, MD, PhD, Pasquale Mastroroberto,
Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients  Staffan Bjessmo, MD,
The relationship between perioperative temperature and adverse outcomes after off- pump coronary artery bypass graft surgery  Edward L. Hannan, PhD, Zaza.
Donald S. Likosky, PhD, Lawrence J. Dacey, MD, Yvon R
Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS 
Ravi K. Ghanta, MD, Prem S. Shekar, MD, Siobhan McGurk, BS, Donna M
Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery  Chuntao Wu, MD, PhD, Edward L. Hannan,
Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients  Jeevan Nagendran, MD, PhD, Colleen M. Norris,
Early and Late Outcomes of Cardiac Surgery in Octogenarians
Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter?  Asvin M. Ganapathi,
Risk of Valve-Related Events After Aortic Valve Repair
Kim I. de la Cruz, MD, Faisal G
Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J
Presentation transcript:

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality  Edward L. Hannan, PhD, Zaza Samadashvili, MD, Stephen J. Lahey, MD, Craig R. Smith, MD, Alfred T. Culliford, MD, Robert S.D. Higgins, MD, Jeffrey P. Gold, MD, Robert H. Jones, MD  The Annals of Thoracic Surgery  Volume 87, Issue 6, Pages 1741-1749 (June 2009) DOI: 10.1016/j.athoracsur.2009.02.058 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Survival after isolated aortic valve replacement versus aortic valve replacement with concomitant coronary artery bypass grafting. Dashed lines are survival for age- and sex-matched US population. Solid and dash-dotted lines represent survival for aortic valve replacement patients with and without concomitant coronary artery bypass grafting, respectively. (A) Unadjusted Kaplan-Meier survival curves. (B) Adjusted Kaplan-Meier survival curves. The Annals of Thoracic Surgery 2009 87, 1741-1749DOI: (10.1016/j.athoracsur.2009.02.058) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival after aortic valve replacement according to patient age. Dashed lines are survival for age- and sex-matched US population. Solid lines represent risk-adjusted survival in selected age and surgery subgroups. (A) Nonelderly patients (age < 75 years) with isolated aortic valve replacement. (B) Elderly patients (age > 75 years) with isolated aortic valve replacement. (C) Nonelderly patients undergoing aortic valve replacement with coronary artery bypass graft surgery. (D) Elderly patients undergoing aortic valve replacement with coronary artery bypass graft surgery. The Annals of Thoracic Surgery 2009 87, 1741-1749DOI: (10.1016/j.athoracsur.2009.02.058) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Survival after isolated aortic valve replacement according to preoperative cardiac risk factors. Dashed lines are survival for age- and sex-matched US population. Solid and dash-dotted lines represent risk-adjusted survival for patients with and without each risk factor, respectively. (A) Acute myocardial infarction less than 24 hours or hemodynamically unstable. (B) Congestive heart failure. (C) Left ventricular ejection fraction less than 0.40. (D) Combination of congestive heart failure, left ventricular ejection fraction less than 0.40, and acute myocardial infarction less than 24 hours or hemodynamically unstable. The Annals of Thoracic Surgery 2009 87, 1741-1749DOI: (10.1016/j.athoracsur.2009.02.058) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Survival after aortic valve replacement with concomitant coronary artery bypass graft surgery according to preoperative cardiac risk factors. Dashed lines are survival for age- and sex-matched US population. Solid and dash-dotted lines represent risk-adjusted survival for patients with and without each risk factor, respectively. (A) Acute myocardial infarction less than 24 hours or hemodynamically unstable. (B) Congestive heart failure. (C) Left ventricular ejection fraction less than 0.40. (D) Combination of congestive heart failure, left ventricular ejection fraction less than 0.40, and acute myocardial infarction less than 24 hours or hemodynamically unstable. The Annals of Thoracic Surgery 2009 87, 1741-1749DOI: (10.1016/j.athoracsur.2009.02.058) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions